Who owns IKENA ONCOLOGY INC?
- Ticker: IKNA
- CUSIP Number: 45175g108
Tip: Access positions for across all investors
Analyze quarterly positions in Ikena Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ikena Oncology stock
Who bought or sold IKENA ONCOLOGY INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors | 5.0M | $9.9M | 0% | Dec 2023 |
|
| BVF | 4.8M | $9.4M | 50% | Dec 2023 |
|
| OrbiMed Advisors | 3.5M | $7.0M | 11% | Dec 2023 |
|
| Omega Fund Management | 2.2M | $4.4M | 0% | Dec 2023 |
|
| Blue Owl Capital Holdings | 2.0M | $3.8M | 100% | Dec 2023 |
|
| Vanguard Group | 1.5M | $3.0M | 13% | Dec 2023 |
|
| Artal Group | 1000k | $2.0M | -46% | Dec 2023 |
|
| NEA Management Company | 570k | $1.1M | 214% | Dec 2023 |
|
| Laurion Capital Management | 373k | $734k | -30% | Dec 2023 |
|
| Barclays | 245k | $483k | 18% | Dec 2023 |
|
| Citadel Advisors | 178k | $351k | -14% | Dec 2023 |
|
| Charles Schwab Investment Management | 86k | $169k | 23% | Dec 2023 |
|
| Bank of New York Mellon | 71k | $101k | 2% | Mar 2024 |
|
| Jacobs Levy Equity Management | 56k | $111k | -2% | Dec 2023 |
|
| Two Sigma Investments | 51k | $100k | 134% | Dec 2023 |
|
| Bank of America Corporation | 50k | $99k | 68% | Dec 2023 |
|
| Dimensional Fund Advisors | 39k | $76k | -55% | Dec 2023 |
|
| CornerCap Investment Counsel | 36k | $71k | -3% | Dec 2023 |
|
| Rhumbline Advisers | 27k | $53k | 6% | Dec 2023 |
|
| Virtu Financial | 27k | $53k | 130% | Dec 2023 |
|
| Goldman Sachs Group | 24k | $47k | 10% | Dec 2023 |
|
| Jpmorgan Chase & Co | 22k | $44k | 36% | Dec 2023 |
|
| Jane Street | 22k | $44k | 100% | Dec 2023 |
|
| UBS Group | 21k | $42k | 54% | Dec 2023 |
|
| SG Americas Securities | 20k | $40k | 89% | Dec 2023 |
|
| American International | 15k | $30k | 24% | Dec 2023 |
|
| New York State Common Retirement Fund | 15k | $30k | 0% | Dec 2023 |
|
| Royal Bank of Canada | 11k | $20k | 155% | Dec 2023 |
|
| Wells Fargo & Company | 9.5k | $19k | 55% | Dec 2023 |
|
| Citigroup | 4.6k | $9.1k | 46210% | Dec 2023 |
|
| Baystate Wealth Management | 3.0k | $5.9k | 0% | Dec 2023 |
|
| Legal & General Group | 2.0k | $4.0k | 0% | Dec 2023 |
|
| Summit Investment Advisors | 1.8k | $3.5k | 0% | Dec 2023 |
|
| Amalgamated Bank | 717.00 | $999.999900 | -61% | Mar 2024 |
|
| CWM | 3.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Ikena Oncology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| venBio Select Advisor | Sep 2023 | 1.6M | $7.1M |
| Vida Ventures Advisors | Dec 2023 | 225k | $444k |
| Fred Alger Management | Sep 2023 | 43k | $186k |
| Mirae Asset Global Investments | Sep 2023 | 13k | $55k |
| Farther Finance Advisors | Sep 2023 | 50.00 | $217.000000 |